June 19, 2018, Melbourne, Australia.
Australian nasal and respiratory technology company Rhinomed (ASX:RNO) is pleased to advise investors that it has expended its relationship with one of America’s largest pharmacy retailer – CVS.
The Company has now received initial purchase orders confirming that Mute will be stocked on the shelves of over 1100 new CVS pharmacies across the USA. Rhinomed’s Mute technology is currently stocked in approximately 100 CVS stores, so this development represents a 10 fold plus expansion in store count. Mute is now stocked in over 9,000 stores in the US alone.